MedPath

A Comparative Clinical trial to study the effect of Takradhara and Shiro-abhyang with Yashtimadhuadya Tail in the management of Generalized Anxiety Disorder

Phase 2/3
Not yet recruiting
Conditions
Generalized anxiety disorder. Ayurveda Condition: chittodvega,
Registration Number
CTRI/2021/09/036359
Lead Sponsor
shubhdeep ayurved medical college
Brief Summary

The study of randomized interventional comparative clinical study of takradhara and shiro-abhyang with yashtimadhuadhya tail in chittodvega (generalized anxiety disorder). Total 60 patients will be enrolled in present study. Selected patients will be divided into two groups on the basis of computer generated randomization.

GROUP A 30 patients will be given takradhara for 7 days



GROUP B 30 patients will be given shiro-abhyang with yashtimadhuadhya tail

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1 DSM-IV 2 patients with anxiety from last 6 months.

Exclusion Criteria

1 patients above 70 and below 20 years of age 2 patients with any severe systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in classical sign and symptoms of chittodvega (At the time of baseline and at the end of the treatment)Total study period 12 months and treatment period 3 weeks
Secondary Outcome Measures
NameTimeMethod
Assessment of change in the clinical parametersTotal study period 12 months and Treatment period 3 weeks

Trial Locations

Locations (1)

Shubhdeep Ayurved Medical College

🇮🇳

Indore, MADHYA PRADESH, India

Shubhdeep Ayurved Medical College
🇮🇳Indore, MADHYA PRADESH, India
Dr Swati Parmar
Principal investigator
8878444476
drswati.parmar123@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.